Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence.
Anson T KuUma T ShankavaramShana Y TrostelHong ZhangHoussein Abdul SaterStephanie A HarmonNicole V CarrabbaYang LiuBradford J WoodPeter A PintoPeter C BlackRadka StoyanovaElai DavicioniAlan PollackIsmail Baris TurkbeyAdam G SowalskyDeborah E CitrinPublished in: medRxiv : the preprint server for health sciences (2023)
This research was supported by the Prostate Cancer Foundation, the Department of Defense Congressionally Directed Medical Research Program, National Cancer Institute, and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.